EDNRA and ovarian cancer: In addition, in response to ETAR activation (via ET-1), β-arrestin 1 increases its nuclear localization and binds to nuclear β-catenin, thereby enhancing β-catenin transcriptional activity, a central path in ovarian cancer [6,7].